期刊
CALCIFIED TISSUE INTERNATIONAL
卷 87, 期 2, 页码 99-107出版社
SPRINGER
DOI: 10.1007/s00223-010-9372-1
关键词
Osteoporosis; Sclerosteosis; van Buchem disease; Sclerostin; Wnt signaling; Osteocyte
资金
- European Commission [HEALTH-F2-2008-201099]
- Agentschap NL/IOP Genomics [IGE07001A]
In recent years study of rare human bone disorders has led to the identification of important signaling pathways that regulate bone formation. Such diseases include the bone sclerosing dysplasias sclerosteosis and van Buchem disease, which are due to deficiency of sclerostin, a protein secreted by osteocytes that inhibits bone formation by osteoblasts. The restricted expression pattern of sclerostin in the skeleton and the exclusive bone phenotype of good quality of patients with sclerosteosis and van Buchem disease provide the basis for the design of therapeutics that stimulate bone formation. We review here current knowledge of the regulation of the expression and formation of sclerostin, its mechanism of action, and its potential as a bone-building treatment for patients with osteoporosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据